February 2017

Drug Developers Use Google Cloud HPC in the Fight Against ALS

Within the haystack of a lethal disease such as ALS (amyotrophic lateral sclerosis / Lou Gehrig’s Disease ... proportions for scientists at pharmaceutical companies, medical research centers and academic institutions. As models grow in scale so too ...

Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Estimated to Grow Strongly by 2016 – 2022

Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects ... 90–95% of the overall cases in US and the government initiatives to examination the research for rare disease and FDA approvals creates an opportunity for various market ...

Fundraising and Special Events Internship

The Amyotrophic Lateral Sclerosis (ALS) Association is the only national not ... Association is to lead the fight to cure and treat ALS through global, cutting-edge research, and to empower people with Lou Gehrig's disease and their families to live ...

Children of patients with C9orf72 mutations are at a greater risk of frontotemporal dementia or ALS at a younger age

Christine Van Broeckhoven (VIB-UAntwerp): "This research is based on our team's previous ... associated with neurodegeneration Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are two brain diseases associated with neurodegeneration ...

Children of patients with C9orf72 mutations: Greater risk of frontotemporal dementia/ALS

This research was conducted by physician and PhD student ... in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study, 2012). The molecular studies of the ...

How Lou Gehrig's disease progression could be delayed

A team of biomedical scientists has identified a molecule that targets a gene known to play a critical role in the rapid progression of amyotrophic lateral sclerosis (ALS), sometimes ... muscles of the body. The research, done on a mouse model of ALS ...

Spinal cord morphometry — a promising technique to track disease course in ALS

Measurement of the cross-sectional area of the cervical spinal cord could aid the tracking of disease progression in amyotrophic lateral sclerosis (ALS), according to research published in NeuroImage: Clinical. A team at the University of Campinas ...

Advancements in ALS Treatment with Stem Cell Research

ALS or amyotrophic lateral sclerosis is an incurable disease ... Over the last few years, research for a better ALS Treatment has advanced rapidly. Researchers now understand the disease better, and are on their way to develop potential treatment options ...

VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy VM202 in Amyotrophic Lateral Sclerosis (ALS)

About Amyotrophic Lateral Sclerosis Amyotrophic lateral sclerosis (ALS), also ... ViroMed has assembled a diverse yet technologically and conceptually linked pipeline. Other research areas include therapeutic DNA vaccine for cancer, recombinant protein ...

Heavy Metal Pollution May Not Lead to Higher ALS Incidence, Italian Study Suggests

The study, “Incidence of amyotrophic lateral sclerosis in the province of Novara ... Genetic and Nutritional Epidemiology Research Center (REAGAN) and Reggio Emilia of Modena — analyzed the incidence of ALS between 2002 and 2012 in Novara.

February 2017

Drug Developers Use Google Cloud HPC in the Fight Against ALS

Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Estimated to Grow Strongly by 2016 – 2022

Fundraising and Special Events Internship

Children of patients with C9orf72 mutations are at a greater risk of frontotemporal dementia or ALS at a younger age

Children of patients with C9orf72 mutations: Greater risk of frontotemporal dementia/ALS

How Lou Gehrig's disease progression could be delayed

Spinal cord morphometry — a promising technique to track disease course in ALS

Advancements in ALS Treatment with Stem Cell Research

VM BioPharma Announces Publication of Phase 1/2 Clinical Data of Novel Gene Therapy VM202 in Amyotrophic Lateral Sclerosis (ALS)

Heavy Metal Pollution May Not Lead to Higher ALS Incidence, Italian Study Suggests

Pages

Keep in touch

Be a team player

Learn about ALS

Get help

You are here

February 2017

Pages

Keep in touch

Be a team player

Learn about ALS

Get help